DXCM vs IPAR · P/E 63, rev $2.50B vs P/E 17, rev $685.9M
DexCom Inc (DXCM) versus Inter Parfums Inc (IPAR) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Inter Parfums Inc (IPAR) is a household & personal products company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported IPAR revenue for 2026-06-30 was $685.9M. Net income was $73.9M. Revenue was up 98.9% from 2026-03-31 to 2026-06-30. IPAR currently screens at market cap $2.92B and trailing P/E 17.3.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. IPAR currently screens at market cap $2.92B and trailing P/E 17.3.
Not investment advice. Open the DXCM and IPAR stock pages for the full models.
Not investment advice.